Back to Search
Start Over
Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
- Source :
-
Health care for women international [Health Care Women Int] 2015; Vol. 36 (10), pp. 1072-80. Date of Electronic Publication: 2014 Oct 30. - Publication Year :
- 2015
-
Abstract
- Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.
- Subjects :
- Adult
Case-Control Studies
Female
Humans
Immunoglobulins, Intravenous pharmacology
Multiple Sclerosis complications
Multiple Sclerosis physiopathology
Pregnancy
Pregnancy Complications drug therapy
Pregnancy Complications immunology
Pregnancy Outcome
Puerperal Disorders prevention & control
Recurrence
Retrospective Studies
Risk Assessment
Risk Factors
Treatment Outcome
Immunoglobulins, Intravenous therapeutic use
Mothers
Multiple Sclerosis drug therapy
Multiple Sclerosis, Relapsing-Remitting prevention & control
Postpartum Period drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1096-4665
- Volume :
- 36
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Health care for women international
- Publication Type :
- Academic Journal
- Accession number :
- 25187102
- Full Text :
- https://doi.org/10.1080/07399332.2014.948627